Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

What we need is public health education, not finger pointing

Although I do not disagree with Anthony Cox’s views on selling only evidence-based over-the-counter (OTC) medicines (The Pharmaceutical Journal 2014;293:176), his views are those of an academic working in a university and not from a pharmacist standing at a medical counter facing a sales executive requesting a cure for a dry cough before a vital presentation in half an hour, or a bride asking for a miracle cure for a cold before her wedding the next day.

Ingredients of most OTC products do not have evidence based on double blind, crossover clinical trials and pharmaceutical companies do not have any commercial incentive to carry out such costly trials for these non-patentable ingredients.

Faced with such customers requesting a cure, I would explain the nature of the self-limiting minor ailment if they have the time to listen and supply a suitable product despite lack of evidence. There are also customers who will demand a product they have seen advertised on the television the night before.

Millions of pounds are spent by the public on vitamins and minerals by self-selection, which experts say are a waste of money.

I do not underestimate the placebo effect of these products. We all know customers willing to pay an extortionate price for a branded ibuprofen because “it works better than the cheap generic”.

We supply licensed products for minor ailments. If we did not, the next port of call would be the GP — if they can get an appointment — or the overstretched A&E departments.

If Cox has questions about the efficacy of these products, he should address them to the Medicines and Healthcare products Regulatory Agency.

He should realise we deal with millions of members of the public who are not educated in academic institutions but by “Dr Google” in the internet age. What is required is public health education rather than blaming pharmacists for selling products promoted by global pharmaceutical companies.

U. A. Patel

Northwood, Middlesex

Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2014.20066463

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.